Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Maria R. Emma, Giuseppa Augello, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, Melchiorre Cervello & James A. McCubrey. (2019) RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma. Expert Opinion on Therapeutic Targets 23:11, pages 915-929.
Read now
Read now
Articles from other publishers (12)
Yang Sun, Wei Nie, Bo Qiu, Qi Yang & Huanhuan Zhao. (2022) FBXW7 affects autophagy through MCL1 in oral squamous cell carcinoma. Oral Diseases.
Crossref
Crossref
Zequan Zhou, Suohui Zhang, Guozhong Yang & Yunhua Gao. (2021) Enhanced delivery efficiency and sustained release of biopharmaceuticals by complexation-based gel encapsulated coated microneedles: rhIFNα-1b example. Asian Journal of Pharmaceutical Sciences 16:5, pages 612-622.
Crossref
Crossref
Ann-Kathrin Eichelmann, George C. Mayne, Karen Chiam, Steven L. Due, Isabell Bastian, Frederike Butz, Tingting Wang, Pamela J. Sykes, Nicholas J. Clemons, David S. Liu, Michael Z. Michael, Christos S. Karapetis, Richard Hummel, David I. Watson & Damian J. Hussey. (2021) Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression. International Journal of Molecular Sciences 22:11, pages 5547.
Crossref
Crossref
Mohammad rafi Khezri, Hassan Malekinejad, Naime Majidi-Zolbanin & Morteza Ghasemnejad-Berenji. (2021) Anticancer potential of metformin: focusing on gastrointestinal cancers. Cancer Chemotherapy and Pharmacology 87:5, pages 587-598.
Crossref
Crossref
Ming Li & Wei Ma. (2021) miR-26a Reverses Multidrug Resistance in Osteosarcoma by Targeting MCL1. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Paul HolvoetPaul Holvoet. 2021. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer
149
211
.
Anthony J. Sannicandro, Brian McDonagh & Katarzyna Goljanek-Whysall. (2020) MicroRNAs as potential therapeutic targets for muscle wasting during cancer cachexia. Current Opinion in Clinical Nutrition & Metabolic Care 23:3, pages 157-163.
Crossref
Crossref
Shuang‐Sang Fang, Jin‐Cheng Guo, Jian‐Hua Zhang, Jin‐Na Liu, Shuai Hong, Bo Yu, Yuhan Gao, Su‐Pei Hu, Hai‐Zhong Liu, Liang Sun & Yi Zhao. (2019) A P53‐related microRNA model for predicting the prognosis of hepatocellular carcinoma patients. Journal of Cellular Physiology 235:4, pages 3569-3578.
Crossref
Crossref
Libin Zhang, Jing Hu, Menghui Hao & Liang Bu. (2020) Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis. Biological Chemistry 401:3, pages 407-416.
Crossref
Crossref
Lisa Linck-Paulus, Claus Hellerbrand, Anja K. Bosserhoff & Peter Dietrich. (2020) Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma. Cells 9:1, pages 114.
Crossref
Crossref
Huapeng Zhang, Gongquan Li, Guanghui Chen, Yi Zhang, Jie Pan, Hongwei Tang, Jie Li, Wenzhi Guo & Shuijun Zhang. (2019) Targeting Mcl-1 inhibits survival and self-renewal of hepatocellular cancer stem-like cells. Clinics and Research in Hepatology and Gastroenterology 43:3, pages 292-300.
Crossref
Crossref
Wenhua Zhao, Gengyang Shen, Hui Ren, De Liang, Xiang Yu, Zhida Zhang, Jinjing Huang, Ting Qiu, Jingjing Tang, Qi Shang, Peiyuan Yu, Zixian Wu & Xiaobing Jiang. (2018) Therapeutic potential of microRNAs in osteoporosis function by regulating the biology of cells related to bone homeostasis. Journal of Cellular Physiology 233:12, pages 9191-9208.
Crossref
Crossref